Government Archives - Page 55 of 268

2 minute read

Bitcoin ETF Watch: SEC Reportedly Meets With Big Players, Demands Final Touches By This Deadline

December 25, 2:46 PM

Officials from the Securities and Exchange Commission reportedly engaged in meetings on Thursday with delegates from seven firms, all vying to introduce Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs).

BLK

2 minute read

Elon Musk’s Yuletide Grudge: Tesla CEO Still Cross With Biden For Giving ‘Cold Shoulder’ 2 Years Ago

By Ramakrishnan M

December 25, 11:00 AM

Musk expressed his frustration, emphasizing the White House's decision to exclude Tesla from a 2021 EV summit, and lauding General Motors.

TSLA

2 minute read

Year-End Planning: How To Make Winnings Out Of Losses Using Tax-Loss Harvesting

By Neil Dennis

December 25, 8:22 AM

Losses from unprofitable asset sales can be offset against capital gains tax on winning trades.

IAT

1 minute read

As Another Legal Challenge Looms, New York’s Marijuana Program Remains A Must-Watch Emerging Market In 2024

By Nicolas Jose Rodriguez

December 22, 5:22 PM

Two companies, Variscite New York Four LLC and Variscite New York Five LLC, filed a lawsuit against New York's Office of Cannabis Management (OCM), arguing the state's cannabis licensing program unfairly

CURLF

4 minute read

Bill Banning Wrongful DUI Cannabis Arrests, Interstate Marijuana Commerce Puts CA In Jeopardy And More

By Jelena Martinovic

December 22, 11:44 AM

California AG Warns Of Major Risks Of Interstate Marijuana Sales California’s Attorney General Rob Bonta made it clear…

CSE:TRUL

2 minute read

Why Engine Manufacturer Cummins Shares Are Down Today

By Lekha Gupta

December 22, 10:37 AM

Cummins Inc (NYSE: CMI) shares are trading lower after it penned an agreement in principle to resolve the U.S.

CMI

2 minute read

Why Is NetEase Stock Plummeting Friday?

By Anusuya Lahiri

December 22, 10:34 AM

NetEase, Inc (NASDAQ: NTES) stock is trading lower Friday as Chinese regulators introduced sweeping regulations targeting the

NTES

1 minute read

Outlook Therapeutics Clocks FY23 EPS Loss of (0.24) Vs $(0.31) YoY, Cash and Equivalents of $23.4M and Reiterated ONS-5010 Clinical and Regulatory Path Forward in the US and EU

By Benzinga Newsdesk

December 22, 9:08 AM

Upcoming Anticipated Milestones FDA response on NORSE EIGHT Special Protocol Assessment (SPA) in early February 2024; Commencement of NORSE EIGHT expected in first calendar quarter of 2024; MAA decision date in the

OTLK